Unresolved issues in prophylaxis.
Brown
S A
SA
Katharine Dormandy Haemophilia Centre & Haemostasis Unit, Royal Free Hospital, London, UK. simon.brown@rfh.nthames.nhs.uk
Aledort
L M
LM
Astermark
J
J
Berntorp
E
E
van den Berg
M
M
Blanchette
V
V
Donfield
S
S
Gringeri
A
A
Hilgartner
M
M
Kulkarni
R
R
Leissinger
C
C
Negrier
C
C
Nuss
R
R
Petterson
H
H
Petrini
P
P
Poulios
N
N
Schramm
W
W
D004334:Drug Administration Schedule; D005164:Factor IX / Q000008:administration & dosage; D005169:Factor VIII / Q000008:administration & dosage; D017048:Health Care Costs; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D002836:Hemophilia B / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007592:Joint Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D011788:Quality of Life
D005169:Factor VIII; D005164:Factor IX